Idera Pharmaceuticals Inc (IDRA)

[kld2]

Why is IDERA different from other biotechs with one or two potential "blockbuster" drugs? Simply put: 3GA. It is a platform, a compound factory. Right now they have 22 compounds that target 22 genes. In 2018, one or more compounds will go into clinical trials. You can bet, if preliminary data is encouraging, the share price will explode. I mean billions of dollars explode. Look at IONS; 2GA. 5b mc. 20x IDERA. And that's why, LT, IDERA is such a good investment: the risk/reward is great. No one says they will succeed; 91% fail. But IDERA, if it does succeed, will do it brilliantly.